+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "JAK Inhibitor"

Inflammatory bowel disease (IBD) Therapeutics Market- Growth, Trends, Covid-19 Impact, and Forecasts (2022 - 2027) - Product Thumbnail Image

Inflammatory bowel disease (IBD) Therapeutics Market- Growth, Trends, Covid-19 Impact, and Forecasts (2022 - 2027)

  • Report
  • August 2022
  • 110 Pages
  • Global
From
JAK inhibitors - Competitive Landscape, 2023 - Product Thumbnail Image

JAK inhibitors - Competitive Landscape, 2023

  • Report
  • April 2023
  • 180 Pages
  • Global
From
RINVOQ Market Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

RINVOQ Market Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • January 2023
  • 30 Pages
  • Global
From
RINVOQ Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

RINVOQ Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • January 2023
  • 30 Pages
  • Global
From
OLUMIANT Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

OLUMIANT Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • January 2023
  • 30 Pages
  • Global
From
XELJANZ Market Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

XELJANZ Market Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • January 2023
  • 30 Pages
  • Global
From
OLUMIANT Market Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

OLUMIANT Market Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • December 2022
  • 30 Pages
  • Global
From
Aicardi Goutieres Syndrome - Epidemiology Forecast - 2032 - Product Thumbnail Image

Aicardi Goutieres Syndrome - Epidemiology Forecast - 2032

  • Report
  • August 2022
  • 62 Pages
  • Global
From
Global Janus Kinase (JAK) Inhibitors Market 2022-2026 - Product Thumbnail Image

Global Janus Kinase (JAK) Inhibitors Market 2022-2026

  • Report
  • February 2022
  • 120 Pages
  • Global
From
Atopic Dermatitis Market Size, Share and Trends Analysis by Region, Drug Class (Corticosteroids, Calcineurin Inhibitors, PDE4 Inhibitors, Biologics, Others), Route of Administration (Injectable, Oral, Topical) and Segment Forecast, 2022-2027 - Product Thumbnail Image

Atopic Dermatitis Market Size, Share and Trends Analysis by Region, Drug Class (Corticosteroids, Calcineurin Inhibitors, PDE4 Inhibitors, Biologics, Others), Route of Administration (Injectable, Oral, Topical) and Segment Forecast, 2022-2027

  • Report
  • November 2022
  • 107 Pages
  • Global
From
Crohn's Disease - Global Drug Forecast and Market Analysis to 2029 - Product Thumbnail Image

Crohn's Disease - Global Drug Forecast and Market Analysis to 2029

  • Report
  • September 2020
  • 148 Pages
  • Global
From
Psoriatic Arthritis: Global Drug Forecast and Market Analysis to 2028 - Product Thumbnail Image

Psoriatic Arthritis: Global Drug Forecast and Market Analysis to 2028

  • Report
  • January 2020
  • 130 Pages
  • Global
From
Axial Spondyloarthritis: Global Drug Forecast and Market Analysis to 2028 - Product Thumbnail Image

Axial Spondyloarthritis: Global Drug Forecast and Market Analysis to 2028

  • Report
  • October 2019
  • 128 Pages
  • Global
From
Atopic Dermatitis: Global Drug Forecast and Market Analysis to 2027 - Product Thumbnail Image

Atopic Dermatitis: Global Drug Forecast and Market Analysis to 2027

  • Report
  • November 2018
  • 108 Pages
  • Global
From
KOL Perspectives: Treatment strategies for pregnant RA patients - Product Thumbnail Image

KOL Perspectives: Treatment strategies for pregnant RA patients

  • Drug Pipelines
  • July 2018
  • 27 Pages
  • Global
From
Crohn's Disease Forecast and Market Analysis to 2026 - Product Thumbnail Image

Crohn's Disease Forecast and Market Analysis to 2026

  • Report
  • August 2018
  • 679 Pages
  • Global
From
Global Atopic Dermatitis Drugs Market Size, Share & Industry Trends Analysis Report By Route of Administration, By Class (Biologics, Calcineurin Inhibitors, Corticosteroids, PDE4 Inhibitors), By Regional Outlook and Forecast, 2022 - 2028 - Product Thumbnail Image

Global Atopic Dermatitis Drugs Market Size, Share & Industry Trends Analysis Report By Route of Administration, By Class (Biologics, Calcineurin Inhibitors, Corticosteroids, PDE4 Inhibitors), By Regional Outlook and Forecast, 2022 - 2028

  • Report
  • November 2022
  • 175 Pages
  • Global
From
Global Non-steroidal Anti-inflammatory Drugs Market Size, Share & Industry Trends Analysis Report By Route of Administration (Oral, Topical and Others), By Distribution Channel, By Route of Disease Indication, By Regional Outlook and Forecast, 2022 - 2028 - Product Thumbnail Image

Global Non-steroidal Anti-inflammatory Drugs Market Size, Share & Industry Trends Analysis Report By Route of Administration (Oral, Topical and Others), By Distribution Channel, By Route of Disease Indication, By Regional Outlook and Forecast, 2022 - 2028

  • Report
  • July 2022
  • 225 Pages
  • Global
From
Europe Ulcerative Colitis Market Size, Share & Industry Trends Analysis Report By Molecule Type (Small Molecules and Biologics), By Disease Type, By Route of Administration, By Country and Growth Forecast, 2022-2028 - Product Thumbnail Image

Europe Ulcerative Colitis Market Size, Share & Industry Trends Analysis Report By Molecule Type (Small Molecules and Biologics), By Disease Type, By Route of Administration, By Country and Growth Forecast, 2022-2028

  • Report
  • April 2022
  • 85 Pages
  • Europe
From
Global Inflammatory Bowel Disease Treatment Market By Type, By Distribution Channel, By Route of Administration, By Drug Class, By Regional Outlook, Industry Analysis Report and Forecast, 2021 - 2027 - Product Thumbnail Image

Global Inflammatory Bowel Disease Treatment Market By Type, By Distribution Channel, By Route of Administration, By Drug Class, By Regional Outlook, Industry Analysis Report and Forecast, 2021 - 2027

  • Report
  • October 2021
  • 288 Pages
  • Global
From
Loading Indicator

The JAK Inhibitor market is a subset of the larger Immune Disorders Drugs market. JAK Inhibitors are a type of drug used to treat a variety of immune-related disorders, such as rheumatoid arthritis, psoriasis, and Crohn's disease. These drugs work by blocking the activity of Janus kinase (JAK) enzymes, which are involved in the body's inflammatory response. JAK Inhibitors are typically taken orally, and are often used in combination with other medications. The JAK Inhibitor market is highly competitive, with a number of large pharmaceutical companies vying for market share. Some of the major players in the market include AbbVie, Pfizer, Novartis, and Johnson & Johnson. Other companies, such as Celgene, Merck, and Eli Lilly, are also active in the market. Show Less Read more